← FDA Drug Approvals (Drugs@FDA)

DEFLAZACORT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS INC · Approved 2026-01-27

Drug application

FDA Application #

ANDA219930

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFLAZACORT

Generic name

DEFLAZACORT ORAL

Active ingredients

DEFLAZACORT

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

SUN PHARM INDS INC

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2026-01-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown